Brief: Kaleido Biosciences Reports Q2 Results

Kaleido Biosciences

11/08/2021 12:58

Aug 11 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * Q2 LOSS PER SHARE $0.56
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.57 -- REFINITIV IBES
DATA
    * KALEIDO BIOSCIENCES - ADDITIONAL DATA FROM AN
OBSERVATIONAL
CLINICAL STUDY OF KB109 IN PATIENTS WITH MILD-TO-MODERATE
COVID-19 EXPECTED BY END OF Q3
    * CO HAS CASH RUNWAY INTO Q2 OF 2022

Source text for Eikon:  ID:nGNXb8KZHB 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))